Home > News > Introgen Acquires Rights to New Nanotechnology Systems
November 16th, 2006
Introgen Acquires Rights to New Nanotechnology Systems
Abstract:
Introgen Therapeutics,Inc. (Nasdaq: INGN) announced today that it has obtained the exclusive,
worldwide license to a portfolio of patents from The University of Texas M.D. Anderson Cancer Center focused on the delivery of biologically active proteins, polypeptides and peptides using novel nanoparticle delivery complexes.
Source:
Businesswire
Bookmark:
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Patents/IP/Tech Transfer/Licensing
Nanoparticle Opens the Door to Clean-Energy Alternatives June 14th, 2013
DRYWIRED™ Receives MILITARY-STANDARD Certifications from QUANTA LABORATORIES for Its Latest Protective Nano-Coating Technology June 5th, 2013
Apple patents point to slimmer battery tech June 1st, 2013
Patent for Coaxial Nanofibre Production: Scientists from Contipro have patented new jet for effective coaxial nanofibers production May 31st, 2013